期刊
JOURNAL OF CLINICAL MICROBIOLOGY
卷 54, 期 5, 页码 1368-1371出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.03302-15
关键词
-
类别
资金
- Samsung
- nanoMR
- BioFire
- Check-Points
- Curetis
- 3M
- Merck
- Actavis
- Hutchison Biofilm Medical Solutions
- Accelerate Diagnostics
- Allergan
- Medicines Company
- bioMerieux
- Bruker
- Abbott
- Nanosphere
- Siemens
- BD
- TIB
Using a rapid bacterial lysis method, the Check MDR CT103 and CT103 XL microarrays demonstrated accuracies of 98.1% and 94.2%, respectively, for detection of known resistance genes in 108 multidrug-resistant Gram-negative bacilli. In 45 isolates, 49 previously unrecognized extended-spectrum beta-lactamase or plasmid AmpC targets were detected and confirmed by conventional PCR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据